Skip to content

The Clinical Study of Blood Flow Restriction Technique in the Treatment of Osteoporosis

The Clinical Study of Blood Flow Restriction Technique in the Treatment of Osteoporosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056478
Enrollment
Unknown
Registered
2022-02-06
Start date
2022-02-07
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

BFRT combined drug group:BFRT combined with anti osteoporosis drugs
BFRT group:BFRT
drug group:anti osteoporosis drugs

Sponsors

The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. According to the World Health Organization (who) BMD quantitative standard, patients with osteoporosis have stable vital signs, no obvious cognitive impairment and can accept action instructions; 2. Voluntarily receive treatment and fill in the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those with serious heart, liver, kidney, serious diabetes and other endocrine system organic diseases; 2. Those who received drugs and poisons affecting bone calcium metabolism within 3 months; 3. Lower limbs have complications such as osteoarthropathy.

Design outcomes

Primary

MeasureTime frame
BMD;

Secondary

MeasureTime frame
P1NP;CTX;

Countries

China

Contacts

Public ContactLi Ju

The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine

48490441@qq.com+86 13735807172

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026